# All India Institute of Medical Sciences, New Delhi

Source: https://onco.cc/institutions/aiims-delhi/  
OnCo record `aiims-delhi` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

AIIMS New Delhi is India's flagship public medical institute; its Rotary Cancer Hospital and the National Cancer Institute campus at Jhajjar anchor government cancer research, and its investigators lead Indian studies in paediatric oncology, gallbladder cancer, PSMA radioligand therapy and low-cost CAR-T.

## Summary

AIIMS New Delhi was created by an Act of Parliament in 1956 as India's flagship medical institute and hospital. Cancer care is concentrated in the Dr B.R. Ambedkar Institute Rotary Cancer Hospital, opened in 1983, and in the National Cancer Institute at Jhajjar, Haryana, a large AIIMS-run cancer campus commissioned from 2019 with proton therapy planned and a national biobank and screening research mandate. AIIMS investigators lead Indian studies in paediatric oncology, gallbladder cancer (unusually common in northern India), oral and cervical cancer screening, radiation oncology and nuclear medicine (PSMA and FAPI PET, radioligand therapy), and haematology including low-cost CAR-T development with IIT Bombay partners. It sets national training standards and publishes the largest volume of oncology research of any Indian public institution.

## Fields

- Kind: Institution
- Last checked: 2026-09-09
- Also known as: AIIMS; Dr B.R. Ambedkar Institute Rotary Cancer Hospital; National Cancer Institute Jhajjar
- City: New Delhi, IN
- Type: hospital
- Website: https://www.aiims.edu

## Sources

- Wikipedia: https://en.wikipedia.org/wiki/All_India_Institute_of_Medical_Sciences,_Delhi
- AIIMS New Delhi: https://www.aiims.edu

## Connected records

- technologies: [CAR-T cell therapy](https://onco.cc/technologies/car-t/), [FAPI PET](https://onco.cc/technologies/fapi-pet/), [Gamma Knife](https://onco.cc/technologies/gamma-knife/), [Global oncology and access in low- and middle-income countries](https://onco.cc/technologies/global-oncology-access/), [HPV & HBV vaccination](https://onco.cc/technologies/hpv-vaccine/), [PSMA PET](https://onco.cc/technologies/psma-pet/), [Radioligand therapy (beta emitters)](https://onco.cc/technologies/radioligand-therapy/), [Stereotactic radiosurgery (Gamma Knife, CyberKnife, linac SRS)](https://onco.cc/technologies/radiosurgery-srs/)
- cancers: [Acute lymphoblastic leukaemia](https://onco.cc/cancers/all-leukemia/), [Biliary tract cancer (cholangiocarcinoma)](https://onco.cc/cancers/cholangiocarcinoma/), [Cervical cancer](https://onco.cc/cancers/cervical/), [Head and neck squamous cell carcinoma](https://onco.cc/cancers/head-and-neck/), [Prostate cancer](https://onco.cc/cancers/prostate/)
- fronts: [Prevention & Risk](https://onco.cc/fronts/prevention/), [Radiation Therapy](https://onco.cc/fronts/radiation/), [Radiopharmaceuticals & Theranostics](https://onco.cc/fronts/radiopharma/)
- people: [Nikhil Tandon](https://onco.cc/people/nikhil-tandon/), [Vinod Raina](https://onco.cc/people/raina-vinod/)
- institutions: [National Cancer Grid of India](https://onco.cc/institutions/national-cancer-grid/), [The new AIIMS network (PMSSY)](https://onco.cc/institutions/aiims-network/)

---
JSON: https://onco.cc/api/v1/entities/aiims-delhi.json